ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

SEC filing

ARROWHEAD PHARMACEUTICALS, INC.

ARWR · CIK 879407

4 · Dec 30, 2025 · Anzalone Christopher Richard sold 51.73K shares at $69.13/share ($3.6M); exercised options for 51.73K shares

Anzalone Christopher Richard sold 51.73K shares at $69.13/share ($3.6M); exercised options for 51.73K shares

FORM 4

xslF345X05/wk-form4_1767134792.xmlSEC.gov

Graphics and non-inline formats (not embedded below).